- Advertisement -spot_img
Tuesday, January 25, 2022

Moderna: Preliminary COVID-19 booster data shows good results at Omicron

Moderna said on Monday that a booster dose of its COVID-19 vaccine should provide protection against the fast-spreading Omicron variant.

Moderna said laboratory tests showed that the half-dose booster shot increased levels of so-called neutralizing antibodies capable of fighting Omicrons by 37 times.

And a full-dose booster was even stronger, causing an 83-fold jump in antibody levels, albeit with an increase in common side effects, the company said. While half-dose shots are being used for most Moderna boosters, a full-dose third shot has been recommended for people with weakened immune systems.

Moderna announced the preliminary laboratory data in a press release and has yet to be scientifically reviewed. But a trial by the US National Institutes of Health announced last week by Dr. Anthony Fauci found a similar leap.

Similarly, Pfizer’s trial found that its COVID-19 vaccine produced an equally big jump in omicron-fighting antibodies. Vaccines made by Pfizer and Moderna, both made from mRNA technology, are used by many countries around the world to fight the coronavirus.

Read Also:  EpochTV Review: Two Americas
World Nation News Deskhttps://www.worldnationnews.com
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here